Esophageal cancer remains one of the most challenging malignancies globally, with high mortality rates and limited early detection capabilities. Recent advances in targeted therapies, immunotherapies, and diagnostic techniques have significantly improved patient outcomes. As awareness and early screening programs improve globally, coupled with new drug developments and regulatory approvals, the...